These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31948072)

  • 1. Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer.
    Fionda C; Stabile H; Cerboni C; Soriani A; Gismondi A; Cippitelli M; Santoni A
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.
    Lazarova M; Steinle A
    Front Immunol; 2019; 10():2689. PubMed ID: 31803194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.
    Cortez VS; Cervantes-Barragan L; Robinette ML; Bando JK; Wang Y; Geiger TL; Gilfillan S; Fuchs A; Vivier E; Sun JC; Cella M; Colonna M
    Immunity; 2016 May; 44(5):1127-39. PubMed ID: 27156386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.
    Coyle KM; Hawke LG; Ormiston ML
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIS and TGF-β regulatory pathways influence immunity to bacterial infection.
    McCulloch TR; Rossi GR; Schreuder J; Belz GT; Wells TJ; Souza-Fonseca-Guimaraes F
    Immunology; 2022 Sep; 167(1):54-63. PubMed ID: 35611558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
    Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
    Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
    Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor.
    Tumino N; Martini S; Munari E; Scordamaglia F; Besi F; Mariotti FR; Bogina G; Mingari MC; Vacca P; Moretta L
    Int J Cancer; 2019 Sep; 145(6):1660-1668. PubMed ID: 30856277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype.
    Hawke LG; Whitford MKM; Ormiston ML
    Front Immunol; 2020; 11():1903. PubMed ID: 32983113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.
    Berrien-Elliott MM; Sun Y; Neal C; Ireland A; Trissal MC; Sullivan RP; Wagner JA; Leong JW; Wong P; Mah-Som AY; Wong TN; Schappe T; Keppel CR; Cortez VS; Stamatiades EG; Li MO; Colonna M; Link DC; French AR; Cooper MA; Wang WL; Boldin MP; Reddy P; Fehniger TA
    Immunity; 2019 Sep; 51(3):479-490.e6. PubMed ID: 31402259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
    Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Lymphoid Cells in Protection, Pathology, and Adaptive Immunity During Apicomplexan Infection.
    Ivanova DL; Denton SL; Fettel KD; Sondgeroth KS; Munoz Gutierrez J; Bangoura B; Dunay IR; Gigley JP
    Front Immunol; 2019; 10():196. PubMed ID: 30873151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
    Gao Y; Souza-Fonseca-Guimaraes F; Bald T; Ng SS; Young A; Ngiow SF; Rautela J; Straube J; Waddell N; Blake SJ; Yan J; Bartholin L; Lee JS; Vivier E; Takeda K; Messaoudene M; Zitvogel L; Teng MWL; Belz GT; Engwerda CR; Huntington ND; Nakamura K; Hölzel M; Smyth MJ
    Nat Immunol; 2017 Sep; 18(9):1004-1015. PubMed ID: 28759001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting Natural Killer Cell-Based Cancer Immunotherapy with Selenocystine/Transforming Growth Factor-Beta Inhibitor-Encapsulated Nanoemulsion.
    Liu C; Lai H; Chen T
    ACS Nano; 2020 Sep; 14(9):11067-11082. PubMed ID: 32806028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.
    Bilotta MT; Abruzzese MP; Molfetta R; Scarno G; Fionda C; Zingoni A; Soriani A; Garofalo T; Petrucci MT; Ricciardi MR; Paolini R; Santoni A; Cippitelli M
    FASEB J; 2019 Aug; 33(8):9489-9504. PubMed ID: 31125275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells.
    Choi SH; Cho HB; Choi JH; Kim HJ; Jang HJ; Cho S; Maeng E; Park H; Ryu KS; Park KH; Park KS
    J Control Release; 2024 Mar; 367():768-778. PubMed ID: 38341178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
    Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C
    Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.